https://scholars.lib.ntu.edu.tw/entities/publication/7291c0f6-d0fd-4bd7-827d-d8e247c31949
Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
Background: Troglitazone (TGZ) is a potential anticancer agent. Little is known about the effect of this agent on cancer cell migration. Methods: Human ovarian...
cell motilityin humaninhibition
https://scholars.lib.ntu.edu.tw/entities/publication/2782dcb4-40ec-43d9-9968-89d6b903067c
Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin...
of the
https://adisinsight.springer.com/drugsafety/800625155?error=cookies_not_supported&code=d99b4e0a-933a-4c6a-ae66-618b34a52e24
Labelled warning added to troglitazone in US - AdisInsight
Parke Davis, the manufacturer of troglitazone [`Rezulin'] is changing prescribing information and adding a warning about liver injury to labelling of the
in uslabelledwarningaddedadisinsight